Neurosurg Focus. 2006 Apr 15;20(4):E5.

Recurrent glioblastoma multiforme: a review of natural history and management options.

Source

Department of Neurosurgery, Stanford University School of Medicine, Stanford, California 94305-5327, USA.

Abstract

Glioblastoma multiforme (GBM) is one of the most aggressive primary brain tumors, with a grim prognosis despite maximal treatment. Advancements in the past decades have not significantly increased the overall survival of patients with this disease. The recurrence of GBM is inevitable, its management often unclear and case dependent. In this report, the authors summarize the current literature regarding the natural history, surveillance algorithms, and treatment options of recurrent GBM. Furthermore, they provide brief discussions regarding current novel efforts in basic and clinical research. They conclude that although recurrent GBM remains a fatal disease, the literature suggests that a subset of patients may benefit from maximal treatment efforts. Nevertheless, further research effort in all aspects of GBM diagnosis and treatment remains essential to improve the overall prognosis of this disease.

PMID:: 16709036; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Other Literature Sources

COS Scholar Universe

Medical

Brain Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme. [Neurosurg Focus. 2006]
Review Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme.
Chang SM, Butowski NA, Sneed PK, Garner IV. Neurosurg Focus. 2006 Apr 15; 20(4):E4. Epub 2006 Apr 15.
Review Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme. [Technol Cancer Res Treat. 2008]
Review Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.
Parvez T. Technol Cancer Res Treat. 2008 Jun; 7(3):241-8.
Review Glioblastoma multiforme: evidence-based approach to therapy. [Expert Rev Anticancer Ther. 2007]
Review Glioblastoma multiforme: evidence-based approach to therapy.
Nicholas MK. Expert Rev Anticancer Ther. 2007 Dec; 7(12 Suppl):S23-7.
Review Gamma knife surgery for glioblastoma multiforme. [Neurosurg Focus. 2006]
Review Gamma knife surgery for glioblastoma multiforme.
Crowley RW, Pouratian N, Sheehan JP. Neurosurg Focus. 2006 Apr 15; 20(4):E17. Epub 2006 Apr 15.
Review Glioblastoma multiforme: a review of therapeutic targets. [Expert Opin Ther Targets. 2009]
Review Glioblastoma multiforme: a review of therapeutic targets.
Kanu OO, Mehta A, Di C, Lin N, Bortoff K, Bigner DD, Yan H, Adamson DC. Expert Opin Ther Targets. 2009 Jun; 13(6):701-18.

See reviews... See all...

Cited by 10 PubMed Central articles

Characterizing mutational heterogeneity in a glioblastoma patient with double recurrence. [PLoS One. 2012]
Characterizing mutational heterogeneity in a glioblastoma patient with double recurrence.
Nickel GC, Barnholtz-Sloan J, Gould MP, McMahon S, Cohen A, Adams MD, Guda K, Cohen M, Sloan AE, Laframboise T. PLoS One. 2012; 7(4):e35262. Epub 2012 Apr 20.
SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells. [Mol Cancer. 2011]
SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells.
Oppel F, Müller N, Schackert G, Hendruschk S, Martin D, Geiger KD, Temme A. Mol Cancer. 2011 Nov 9; 10:137. Epub 2011 Nov 9.
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo. [Neuro Oncol. 2011]
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo.
Hendruschk S, Wiedemuth R, Aigner A, Töpfer K, Cartellieri M, Martin D, Kirsch M, Ikonomidou C, Schackert G, Temme A. Neuro Oncol. 2011 Oct; 13(10):1074-89. Epub 2011 Jul 25.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Recurrent glioblastoma multiforme: a review of natural history and management op...
Recurrent glioblastoma multiforme: a review of natural history and management options.
Neurosurg Focus. 2006 Apr 15 ;20(4):E5.

PubMed
[Childhood acute lymphoblastic leukemia with t(1;19) lacking E2A-pBX1 chimeric t...
[Childhood acute lymphoblastic leukemia with t(1;19) lacking E2A-pBX1 chimeric transcripts].
Rinsho Ketsueki. 2005 Jan ;46(1):7-12.

PubMed
Iatrogenic ureteric and bladder injuries in obstetric and gynaecologic surgeries...
Iatrogenic ureteric and bladder injuries in obstetric and gynaecologic surgeries.
East Afr Med J. 2006 Feb ;83(2):79-85.

PubMed
[Neonatal seizure and epileptic attacks in newborn infants. Proposal to a nation...
[Neonatal seizure and epileptic attacks in newborn infants. Proposal to a national care program].
Lakartidningen. 2006 Apr 26-May 2 ;103(17):1320-3.

PubMed
Transcendental explanations and near-death experience.
Transcendental explanations and near-death experience.
Lancet. 1991 Jan 26 ;337(8735):244.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: